<DOC>
	<DOCNO>NCT00427206</DOCNO>
	<brief_summary>The study objective determine liver injury develop alcoholic patient follow 5 day therapeutic acetaminophen dose . Volunteers recruit two community detoxification center take either acetaminophen ( 4g/day ) placebo 5 consecutive day . All subject monitor additional two day follow dosing period . The primary measure aminotransferase measure take baseline Days 2 , 4 , 6 7 . We hypothesize would difference aminotransferase mean group study period .</brief_summary>
	<brief_title>Hepatic Function Alcoholics Following 5 Days Acetaminophen Dosing</brief_title>
	<detailed_description />
	<mesh_term>Alcohol-Related Disorders</mesh_term>
	<mesh_term>Acetaminophen</mesh_term>
	<criteria>18 year older admit participate detox facility positive BAL time admittance sign write informed consent serum acetaminophen level great 20 mcg/ml serum AST ALT level great 200 IU/L INR great 1.5 female , positive betasubunit chorionic gonadotropin ( betaHCG ) clinically intoxicate , psychiatrically impaired unable give inform consent know hypersensitivity acetaminophen history ingest four gram APAP per day four day precede study enrollment currently enrol another trial enrol another trial precede three month .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2009</verification_date>
	<keyword>acetaminophen</keyword>
	<keyword>alcohol</keyword>
	<keyword>liver injury</keyword>
</DOC>